SCHEMBL28243

SCHEMBL28243

COC(=O)CC(O)CC(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.50
HSD17B10 Q99714 2/20 0.46
MGAM O43451 2/20 0.46
GAA P10253 2/20 0.46
SI P14410 2/20 0.46
MGAM2 Q2M2H8 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.43
KMT2A Q03164 2/20 0.37
TET2 Q6N021 1/20 0.37
MEN1 O00255 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 2/20 0.36
CA12 O43570 1/20 0.36
CA14 Q9ULX7 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
MAPT P10636 3/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HTT P42858 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2407894 0.90 SLC22A6 (0.62) TSHRHSD17B10MGAMGAASI
SCHEMBL15976653 0.90 MGAM (0.50) TSHRHSD17B10MGAMGAASI
SCHEMBL12787282 0.90 MGAM (0.50) TSHRHSD17B10MGAMGAASI
SCHEMBL13908456 0.90 MGAM (0.50) TSHRHSD17B10MGAMGAASI
SCHEMBL2413537 0.90 SLC22A6 (0.62) TSHRHSD17B10MGAMGAASI
SCHEMBL2414863 0.90 SLC22A6 (0.62) TSHRHSD17B10MGAMGAASI
SCHEMBL5458599 0.88 TSHR (0.40) TSHRHSD17B10MGAMGAASI
SCHEMBL18914896 0.88 TSHR (0.42) TSHRHSD17B10MGAMGAASI
SCHEMBL14992884 0.88 TSHR (0.40) TSHRHSD17B10MGAMGAASI
SCHEMBL1691447 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110498915-B Simple and controllable synthesis method of alpha-carboxyl-omega-hydroxyl polyether 华南理工大学 2021-09-21 CN claimed
CN-106676141-B Enzymatic preparation method of chiral intermediate (S) -3-hydroxy glutaric acid monoester 浙江京新药业股份有限公司 2020-12-08 CN claimed
CN-110498915-A A kind of α-carboxyl-ω-hydroxy polyethers are simple, controllable synthesis method UNIV SOUTH CHINA TECH 2019-11-26 CN claimed
CN-110407866-A The manufacturing method of silicon compound LANXI LISHUN BIOLOGY CO LTD 2019-11-05 CN claimed
CN-105907094-A Heat-resistant high-elasticity plastic material and preparation method thereof 金宝丽科技(苏州)有限公司 2016-08-31 CN claimed
WO-2011106546-A1 A PROCESS FOR THE PREPARATION OF ROSUVASTATIN INTERMEDIATE TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) 2011-09-01 WO claimed
CN-1251114-A Acid-functionalized polyurethane adducts DOW CHEMICAL CO (US) 2000-04-19 CN claimed
EP-0961795-A1 ACID FUNCTIONALIZED POLYURETHANE ADDUCTS THE DOW CHEMICAL COMPANY (US) 1999-12-08 EP claimed
WO-1998037113-A1 ACID FUNCTIONALIZED POLYURETHANE ADDUCTS THE DOW CHEMICAL COMPANY (US) 1998-08-27 WO claimed
US-12527779-B2 Prostaglandin E2 (PGE2) EP4 receptor antagonists DOMAIN THERAPEUTICS (FR) 2026-01-20 US disclosed
EP-4342957-B1 OIL-RESISTANT AGENT DAIKIN IND LTD (JP) 2025-09-03 EP disclosed
US-12358951-B2 Cyclic peptide antibiotics GENENTECH, INC. (US) 2025-07-15 US disclosed
US-20240141582-A1 OIL-RESISTANT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2024-05-02 US disclosed
EP-4342957-A1 OIL-RESISTANT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2024-03-27 EP disclosed
WO-1998037113-A1 ACID FUNCTIONALIZED POLYURETHANE ADDUCTS THE DOW CHEMICAL COMPANY (US) 1998-08-27 WO disclosed
WO-1997046630-A1 CYANACRYLATE ADHESIVE HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1997-12-11 WO disclosed
EP-0168480-A4 PROCESS FOR PREPARING OPTICALLY-ACTIVE 4-AMINO-3-HYDROXYBUTYRIC ACID. WISCONSIN ALUMNI RES FOUND (US) 1987-10-08 EP disclosed
US-4584270-A ENZYME CLEAVAGE OF ESTER GROUPING OF 3-HYDROXYGLUTARIC ACID DIESTER, FOLLOWED BY CHEMICAL CONVERSION WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1986-04-22 US disclosed
EP-0168480-A1 PROCESS FOR PREPARING OPTICALLY-ACTIVE 4-AMINO-3-HYDROXYBUTYRIC ACID WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1986-01-22 EP disclosed
WO-1985003307-A1 PROCESS FOR PREPARING OPTICALLY-ACTIVE 4-AMINO-3-HYDROXYBUTYRIC ACID WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 1985-08-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12527779-B2 Prostaglandin E2 (PGE2) EP4 receptor antagonists PTGER1, PTGER4, PTGER3 TSHR 606/4885HSD17B10 1102/4885MGAM 4869/4885
US-12358951-B2 Cyclic peptide antibiotics NPPA, LNPEP, CLPP TSHR 2876/4885HSD17B10 2696/4885MGAM 1002/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.